tradingkey.logo

Kamada Ltd

KMDA

7.210USD

-0.010-0.14%
Horarios del mercado ETCotizaciones retrasadas 15 min
414.61MCap. mercado
25.81P/E TTM

Kamada Ltd

7.210

-0.010-0.14%
Más Datos de Kamada Ltd Compañía
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Información de la empresa
Símbolo de cotizaciónKMDA
Nombre de la empresaKamada Ltd
Fecha de salida a bolsaAug 01, 2005
Director ejecutivoMr. Amir London
Número de empleados374
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 01
Dirección2 Holtzman St., Science Park
CiudadREHOVOT
Bolsa de valoresNASDAQ Global Select Consolidated
PaísIsrael
Código postal7670402
Teléfono97289406472
Sitio Webhttps://www.kamada.com/
Símbolo de cotizaciónKMDA
Fecha de salida a bolsaAug 01, 2005
Director ejecutivoMr. Amir London
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+3.12%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Mr. Barak Bashari
Mr. Barak Bashari
Vice President - Operations
Vice President - Operations
--
--
Dr. Michal Stein
Dr. Michal Stein
Vice President and Medical Director for Immunology
Vice President and Medical Director for Immunology
--
--
DR. Michal Ayalon
DR. Michal Ayalon
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
Dr. Estery Giloz-Ran
Dr. Estery Giloz-Ran
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+3.12%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Mr. Barak Bashari
Mr. Barak Bashari
Vice President - Operations
Vice President - Operations
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
U.S.A
30.16M
68.51%
Israel
5.35M
12.16%
Latin America
4.61M
10.48%
Canada
3.04M
6.90%
Asia
790.00K
1.79%
Europe
70.00K
0.16%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
First Israel Mezzanine Investors Ltd.
38.40%
Gov Financial Holdings, Ltd.
4.87%
Phoenix Investment and Finances Ltd
2.88%
Renaissance Technologies LLC
1.41%
Recanati (Leon Yehuda)
1.10%
Other
51.34%
Accionistas
Accionistas
Proporción
First Israel Mezzanine Investors Ltd.
38.40%
Gov Financial Holdings, Ltd.
4.87%
Phoenix Investment and Finances Ltd
2.88%
Renaissance Technologies LLC
1.41%
Recanati (Leon Yehuda)
1.10%
Other
51.34%
Tipos de accionistas
Accionistas
Proporción
Private Equity
38.40%
Corporation
4.87%
Investment Advisor
4.01%
Hedge Fund
2.51%
Individual Investor
2.34%
Investment Advisor/Hedge Fund
2.14%
Research Firm
1.63%
Other
44.08%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
80
32.16M
55.93%
-1.18M
2025Q1
80
31.87M
55.42%
-1.29M
2024Q4
72
32.96M
57.32%
-768.38K
2024Q3
87
33.30M
57.92%
-790.28K
2024Q2
91
33.17M
57.70%
-784.97K
2024Q1
93
32.46M
56.47%
-1.61M
2023Q4
102
32.56M
56.63%
-1.63M
2023Q3
106
34.53M
63.12%
+10.56M
2023Q2
108
21.99M
49.05%
-2.19M
2023Q1
111
22.14M
49.40%
-1.73M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
First Israel Mezzanine Investors Ltd.
22.08M
38.4%
--
--
Dec 31, 2024
Gov Financial Holdings, Ltd.
2.80M
4.87%
-55.95K
-1.96%
Dec 31, 2024
Phoenix Investment and Finances Ltd
1.65M
2.88%
-178.00K
-9.71%
Mar 31, 2025
Renaissance Technologies LLC
808.30K
1.41%
-23.61K
-2.84%
Mar 31, 2025
Recanati (Leon Yehuda)
631.14K
1.1%
--
--
Dec 31, 2024
Wells Fargo Advisors
608.59K
1.06%
-22.10K
-3.50%
Mar 31, 2025
Tsur (David)
607.93K
1.06%
--
--
Dec 31, 2024
Millennium Management LLC
448.19K
0.78%
+130.29K
+40.98%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
412.01K
0.72%
+9.32K
+2.31%
May 31, 2025
More Investment House Ltd.
330.35K
0.57%
-168.57K
-33.79%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
ARK Israel Innovative Technology ETF
1.69%
DFA Dimensional International Small Cap Value ETF
0.01%
DFA Dimensional International Small Cap ETF
0.01%
Schwab International Small-Cap Equity ETF
0%
Avantis International Equity ETF
0%
Dimensional International Core Equity Market ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Vanguard Total World Stock Index Fund
0%
Vanguard ESG International Stock ETF
0%
ARK Israel Innovative Technology ETF
Proporción1.69%
DFA Dimensional International Small Cap Value ETF
Proporción0.01%
DFA Dimensional International Small Cap ETF
Proporción0.01%
Schwab International Small-Cap Equity ETF
Proporción0%
Avantis International Equity ETF
Proporción0%
Dimensional International Core Equity Market ETF
Proporción0%
DFA Dimensional International Core Equity 2 ETF
Proporción0%
Vanguard Total World Stock Index Fund
Proporción0%
Vanguard ESG International Stock ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI